The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Special Article
PreviousPrevious
Volume 338:1516-1520 May 21, 1998 Number 21
NextNext

The Treatment of Unrelated Disorders in Patients with Chronic Medical Diseases
Donald A. Redelmeier, M.D., Siew H. Tan, M.A., and Gillian L. Booth, M.D.

 Sign up for free e-toc
 

This Article
-Full Text
- PDF

Commentary
-Editorial
 by Steinbrook, R.
-Letters

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-PubMed Citation
ABSTRACT

Background Patients can have several illnesses concurrently, yet some of these diseases may be neglected if one problem consumes attention. We conducted a population-based analysis in Ontario, Canada — where universal health insurance is provided — to determine whether unrelated disorders are less likely to be treated in patients with chronic diseases.

Methods We studied the 1,344,145 residents of Ontario in 1995 who were 65 or older and eligible to receive prescription medications free of charge as part of the Ontario Drug Benefit program. Patients with diabetes mellitus were identified by prescriptions for insulin, pulmonary emphysema by prescriptions for ipratropium bromide, and psychotic syndromes by prescriptions for haloperidol. For each chronic disease, we selected an unrelated treatment: estrogen-replacement therapy for patients with diabetes mellitus, lipid-lowering medications for those with pulmonary emphysema, and medical treatment of arthritis for those with psychotic syndromes.

Results The 30,669 patients with diabetes mellitus were less likely to receive estrogen-replacement therapy than the other subjects in the study (2.4 percent vs. 5.9 percent, P<0.001). The disease was associated with a 60 percent reduction in the odds of estrogen treatment (odds ratio, 0.40; 95 percent confidence interval, 0.37 to 0.43). Findings were similar for the 56,779 patients with pulmonary emphysema, who were less likely to receive lipid-lowering medications (odds ratio, 0.69; 95 percent confidence interval, 0.67 to 0.72; P<0.001), and the 17,336 patients with psychotic syndromes, who were less likely to receive medical treatments for arthritis (odds ratio, 0.59; 95 percent confidence interval, 0.57 to 0.62; P<0.001).

Conclusions In patients 65 or older who have chronic medical diseases and who receive prescription medications free of charge, unrelated disorders are undertreated. Clinicians caring for patients with chronic diseases should remain alert to other disorders and minimize the number of missed opportunities for treating them.


Source Information

From the Department of Medicine, University of Toronto (D.A.R., G.L.B.); the Clinical Epidemiology and Health Care Research Program, Sunnybrook Health Science Centre (D.A.R., S.H.T., G.L.B.); and the Institute for Clinical Evaluative Sciences in Ontario (D.A.R., S.H.T.) — all in Toronto.

Address reprint requests to Dr. Redelmeier at the Sunnybrook Health Science Centre, G-151, 2075 Bayview Ave., Toronto, ON M4N 3M5, Canada.

Full Text of this Article


Related Letters:

Treating Unrelated Disorders in Patients with Chronic Disease
Kent D. M., Hayward R., Rubins H. B., Friedman E. A., Poses R. M., Redelmeier D. A., Tan S. H., Booth G. L.
Extract | Full Text  
N Engl J Med 1998; 339:926-928, Sep 24, 1998. Correspondence

This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.